Skip to main content

Table 1 Baseline demographics of patients overall, and stratified by prompt or delayed initiation of FF/UMEC/VI

From: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

 

Total

(N = 1599)

Prompt

(0–30 days)

(N = 393)

Delayed

(31–180 days)

(N = 1206)

Age at index (years)

   

 Mean (SD)

69.8 (10.3)

69.5 (9.8)

69.9 (10.5)

Sex, n (%)

   

 Male

847 (53.0)

218 (55.5)

629 (52.2)

Ethnicity, n (%)

   

 White

1520 (95.1)

376 (95.7)

1144 (94.9)

 Other

22 (1.4)

5 (1.3)

17 (1.4)

 Unknown

57 (3.6)

12 (3.1)

45 (3.7)

Smoking status, n (%)

   

 Current smoker

811 (50.7)

216 (55.0)

595 (49.3)

 Former smoker

788 (49.3)

177 (45.0)

611 (50.7)

BMI (kg/m2)

n = 1429

n = 354

n = 1075

 Mean (SD)

27.3 (6.3)

27.2 (6.4)

27.40 (6.3)

FEV1/FVC ratio

n = 973

n = 251

n = 722

 Mean (SD)

56.3 (14.5)

55.1 (13.7)

56.72 (14.8)

FEV1% predicted

n = 1289

n = 326

n = 963

 Mean (SD)

55.7 (19.5)

53.5 (18.7)

56.41 (19.7)

MRC Dyspnea Scale score, n (%)

   

 Grade 1

114 (7.1)

26 (6.6)

88 (7.3)

 Grade 2

447 (28.0)

110 (28.0)

337 (27.9)

 Grade 3

491 (30.7)

118 (30.0)

373 (30.9)

 Grade 4

322 (20.1)

97 (24.7)

225 (18.7)

 Grade 5

66 (4.1)

15 (3.8)

51 (4.2)

 Unknown

159 (9.9)

27 (6.9)

132 (11.0)

Comorbidities*, n (%)

   

 Depression

738 (46.2)

190 (48.4)

548 (45.4)

 Rheumatoid/osteo arthritis

612 (38.3)

136 (34.6)

476 (39.5)

 Anxiety

505 (31.6)

115 (29.3)

390 (32.3)

 Gastroesophageal reflux disease

450 (28.1)

114 (29.0)

336 (27.9)

 Diabetes

359 (22.5)

88 (22.4)

271 (22.5)

 Stroke

194 (12.1)

42 (10.7)

152 (12.6)

 Acute myocardial infarction

186 (11.6)

45 (11.5)

141 (11.7)

 Congestive heart failure

172 (10.8)

52 (13.2)

120 (10.0)

 Dementia/cognitive impairment

170 (10.6)

39 (9.9)

131 (10.9)

 Bronchiectasis

113 (7.1)

30 (7.6)

83 (6.9)

 Lung cancer

23 (1.4)

5 (1.3)

18 (1.5)

  1. FF/UMEC/VI fluticasone furoate/umeclidinium/vilanterol, SD standard deviation, BMI body mass index, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, MRC Medical Research Council, SNOMED-CT Systematized Nomenclature of Medicine Clinical Terms, ICD-10 International Classification of Disease, 10th Revision
  2. *The presence of specific comorbidities prior to the index date was reported for all patients based on the presence of diagnosis codes (SNOMED-CT and ICD-10) in the patient’s entire medical history